Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.

Authors:
Li X; Deng R; Li J; Li H; Xu Z and 5 more

Journal:
Theranostics

Publication Year: 2023

DOI:
10.7150/thno.85711

PMCID:
PMC10526674

PMID:
37771782

Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing Interests: The authors have declared that no competing interest exists."

Evidence found in paper:

"This work is supported by the Key Research Program of the Chinese Academy of Sciences (QYKJZD-SSW-SLH01) and the National Natural Science Foundation of China (52272048). M. Zhen particularly thanks the Youth Innovation Promotion Association of CAS (2022036). Dedicated to Prof. Chunli Bai on the occasion of his 70th birthday."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025